SI2124997T1 - Uporaba IL antagonista za zdravljenje putike inpsevdo putike - Google Patents

Uporaba IL antagonista za zdravljenje putike inpsevdo putike

Info

Publication number
SI2124997T1
SI2124997T1 SI200731027T SI200731027T SI2124997T1 SI 2124997 T1 SI2124997 T1 SI 2124997T1 SI 200731027 T SI200731027 T SI 200731027T SI 200731027 T SI200731027 T SI 200731027T SI 2124997 T1 SI2124997 T1 SI 2124997T1
Authority
SI
Slovenia
Prior art keywords
pseudogout
antagonists
treat gout
gout
treat
Prior art date
Application number
SI200731027T
Other languages
English (en)
Inventor
Catherine Vicary
Scott Mellis
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SI2124997T1 publication Critical patent/SI2124997T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200731027T 2006-10-20 2007-10-19 Uporaba IL antagonista za zdravljenje putike inpsevdo putike SI2124997T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85338506P 2006-10-20 2006-10-20
EP07839723A EP2124997B1 (en) 2006-10-20 2007-10-19 Use of il-1 antagonists to treat gout and pseudogout
PCT/US2007/022377 WO2008051496A2 (en) 2006-10-20 2007-10-19 Use of il-1 antagonists to treat gout and pseudogout

Publications (1)

Publication Number Publication Date
SI2124997T1 true SI2124997T1 (sl) 2012-11-30

Family

ID=39322920

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200731027T SI2124997T1 (sl) 2006-10-20 2007-10-19 Uporaba IL antagonista za zdravljenje putike inpsevdo putike

Country Status (20)

Country Link
US (1) US20080300185A1 (sl)
EP (1) EP2124997B1 (sl)
JP (1) JP5397948B2 (sl)
CN (1) CN101528252B (sl)
AU (1) AU2007309470B2 (sl)
BR (1) BRPI0718469A2 (sl)
CA (1) CA2666629C (sl)
DK (1) DK2124997T3 (sl)
ES (1) ES2389314T3 (sl)
HR (1) HRP20120896T1 (sl)
IL (1) IL197832A (sl)
MX (1) MX2009004051A (sl)
NZ (1) NZ575972A (sl)
PL (1) PL2124997T3 (sl)
PT (1) PT2124997E (sl)
RS (1) RS52538B (sl)
RU (1) RU2450824C2 (sl)
SG (1) SG175642A1 (sl)
SI (1) SI2124997T1 (sl)
WO (1) WO2008051496A2 (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637029B2 (en) 2007-12-20 2014-01-28 Xoma Technology Ltd. Methods for the treatment of gout
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
RU2603050C2 (ru) * 2011-03-11 2016-11-20 ТиДаблЮАй БАЙОТЕКНОЛОДЖИ, ИНК. Способы и композиции для лечения гиперурикемии и метаболических нарушений, связанных с гиперурикемией
WO2014035361A1 (en) * 2012-08-26 2014-03-06 R-PHARM, CJSC (Closed Joint Stock Company) IL-1β INHIBITOR COMPOSITION AND USE THEREOF
CN105367663A (zh) * 2014-08-31 2016-03-02 复旦大学 一种长效白细胞介素-1受体拮抗剂重组融合蛋白及其制备方法和用途
KR101863604B1 (ko) * 2016-04-08 2018-06-04 한국 한의학 연구원 익지 추출물을 유효성분으로 함유하는 고요산혈증 또는 고요산혈증 관련 대사 장애의 예방, 개선 또는 치료용 조성물
CN110251659A (zh) * 2019-07-03 2019-09-20 安徽省立医院 一种小剂量白细胞介素2在制备治疗慢性痛风药物中的应用
CN116539880B (zh) * 2022-12-05 2023-12-08 四川大学华西医院 检测代谢物和/或组织蛋白的试剂在制备痛风性关节炎筛查试剂盒中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927044B2 (en) * 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
WO2004100987A2 (en) * 2003-05-06 2004-11-25 Regeneron Pharmaceuticals, Inc. Methods of using il-1 antagonists to treat neointimal hyperplasia
US7226553B2 (en) * 2003-07-30 2007-06-05 E. I. Du Pont De Nemours And Company Polymer underwater pelletizer apparatus and process incorporating same
US20050129685A1 (en) * 2003-09-18 2005-06-16 Jingtai Cao Use of IL-1 blockers to prevent corneal inflammation and neovascularization
AU2005249570B2 (en) * 2004-06-04 2011-06-16 Regeneron Pharmaceuticals, Inc. Methods of using IL-1 antagonists to treat autoinflammatory disease
ATE532791T1 (de) * 2004-09-17 2011-11-15 Kissei Pharmaceutical In der 8-stellung modifiziertes purin- nukleosidderivat und dessen medizinische verwendung
WO2006084145A2 (en) * 2005-02-02 2006-08-10 Regeneron Pharmaceuticals, Inc. Methods of using il-1 antagonists to reduce c-reactive protein
WO2007077042A1 (en) * 2006-01-06 2007-07-12 Topotarget Switzerland Sa New method for the treatment of gout or pseudogout

Also Published As

Publication number Publication date
MX2009004051A (es) 2009-05-11
JP5397948B2 (ja) 2014-01-22
EP2124997B1 (en) 2012-08-08
EP2124997A2 (en) 2009-12-02
HRP20120896T1 (hr) 2012-12-31
IL197832A (en) 2014-06-30
AU2007309470A1 (en) 2008-05-02
RS52538B (en) 2013-04-30
US20080300185A1 (en) 2008-12-04
PL2124997T3 (pl) 2013-01-31
WO2008051496A3 (en) 2008-10-30
CA2666629A1 (en) 2008-05-02
ES2389314T3 (es) 2012-10-25
SG175642A1 (en) 2011-11-28
DK2124997T3 (da) 2012-08-27
CN101528252B (zh) 2014-05-28
AU2007309470B2 (en) 2013-05-23
NZ575972A (en) 2011-01-28
IL197832A0 (en) 2011-08-01
JP2010506936A (ja) 2010-03-04
WO2008051496A2 (en) 2008-05-02
CN101528252A (zh) 2009-09-09
CA2666629C (en) 2016-08-16
PT2124997E (pt) 2012-10-24
RU2009118962A (ru) 2010-11-27
BRPI0718469A2 (pt) 2014-01-21
WO2008051496A8 (en) 2009-07-30
RU2450824C2 (ru) 2012-05-20

Similar Documents

Publication Publication Date Title
IL197832A0 (en) Use of il-1 antagonists to treat gout and pseudogout
GB2437617B (en) Slurry injector and methods of use thereof
EP2083734A4 (en) ELECTRODE MARKERS AND APPLICATION METHOD
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
EP2191458A4 (en) FINGER-FITTED DEVICES AND METHODS OF USE THEREOF
EP2097513A4 (en) MANUFACTURE AND USE OF CELLS SYNTHETIZED FIBS
SI2038265T1 (sl) Inhibitorji človeške protein-tirozin-fosfataze in postopki uporabe
IL196181A0 (en) Substituted n-phenylmethyl-5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
HK1147254A1 (en) 5-anilinoimidazopyridines and methods of use 5-
EP2076526A4 (en) NEW SIRNA AND METHOD FOR ITS APPLICATION
EP2023718A4 (en) CREATINLIGATE COMPOUNDS AND APPLICATION METHOD THEREFOR
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
EP2021555A4 (en) STRUCTURAL ELEMENT AND METHODS OF USE THEREOF
GB0719577D0 (en) Microimplant devices and methods of making and use thereof
IL194028A0 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
IL206125A0 (en) Azaindolizines and methods of use
HK1110803A1 (en) Use of baff to treat th2-mediated conditions
HK1115376A1 (en) Inhibitors of mitotic kinesins and their therapeutical use
ZA200904820B (en) Herbicide-resistant sunflower plants and methods of use
EP2037895A4 (en) XYLITOL-PASTILLAS AND METHOD OF USE
GB0624570D0 (en) Floating port and method of use
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
EP2004088A4 (en) DENTAL INSTRUMENT AND METHOD FOR ITS USE
EP2043428A4 (en) MODULATORS OF RNF5 AND USES THEREOF